The Canadian Blood Services Lifetime Achievement Award recognizes individuals whose landmark contributions are both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad.
This prestigious award is now open for nominations for 2021. Read on to learn more about the award, the nomination process and who has been honoured with this award in the past.
Who can be nominated?
To be nominated for the Canadian Blood Services Lifetime Achievement Award, an
individual must have contributed significantly to improving the safety and/or quality of
blood, blood products, stem cells and/or cord blood or has made noteworthy
improvements or advances in transfusion or transplantation medicine practice. Their
record of publication should be of significance and their professional reputation should
be aligned with the goals and reputation of Canadian Blood Services, reflecting a quality
culture driven by excellence.
The award will be presented in September 2021 at the annual national event where we honour our donors, volunteers, peer recruiters and partners from across the country and across our products for their outstanding dedication and achievements.
What's the nomination process?
Note: Candidates should be unaware that they have been nominated for this award.
Submit nominations in writing to the address below:
Canadian Blood Services Lifetime Achievement Award Nominating Committee
c/o Dr. Isra Levy, Vice President, Medical Affairs and Innovation
Canadian Blood Services
1800 Alta Vista Drive
Ottawa, Ontario K1G 4J5
Submission deadline: May 7, 2021
The nominator of the awardee, and the nominee selected, will be notified in early July 2021
The Canadian Blood Services Lifetime Achievement Award came into existence in
2002. To date, the Canadian Blood Services Board of Directors has selected the
following individuals for this prestigious award:
Canadian Blood Services – Driving world-class innovation
Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about .
The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.